Previous close | 4.2000 |
Open | 4.2000 |
Bid | 1.8300 |
Ask | 1.9300 |
Strike | 48.00 |
Expiry date | 2024-10-18 |
Day's range | 4.2000 - 4.2000 |
Contract range | N/A |
Volume | |
Open interest | 93 |
Bristol-Myers Squibb ( NYSE:BMY ) First Quarter 2024 Results Key Financial Results Revenue: US$11.9b (up 4.7% from 1Q...
Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.
PRINCETON, N.J., April 26, 2024--CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine....